LifeVantage Holds its 2nd Annual Canada Leadership Academy
SALT LAKE CITY, Sept. 29, 2017 (GLOBE NEWSWIRE) — LifeVantage Corporation (Nasdaq:LFVN) held its second annual Canada Leadership Academy earlier this month in Vancouver, BC.
More than 450 people attended the highly anticipated event that featured keynote speakers, including LifeVantage President and Chief Executive Officer, Darren Jensen, Senior Vice President of Research and Development, Nathalie Chevreau, and Senior Vice President of Field Development, Dave Fleming.
“For the second straight year, our Canadian distributors and customers demonstrated why there has never been a better time to be part of this great company,” stated LifeVantage President and Chief Executive Officer Darren Jensen. “Their energy and enthusiasm was incredible, and we are already excited to see what next year brings.”
The event’s theme focused on LifeVantage’s new market positioning as a world leader in biohacking, which is the rapidly growing trend of consumers using science to help control their own biology to improve their health and well-being. Speakers also announced new company-wide technology innovations.
“This was an incredible opportunity to talk to our distributors face-to-face,” said Dave Fleming, Senior Vice President of Field Development. “We’re in the middle of an exciting transformation, and Canada is going to play a big part in our future success.”
After the event, attendees were given the opportunity to see the LifeVantage-sponsored Real Salt Lake take on the Vancouver Whitecaps.
About LifeVantage Corporation
LifeVantage Corporation is a science-based health, wellness and anti-aging company dedicated to helping people transform themselves internally and externally at a cellular level. Their scientifically-validated product line includes Protandim® Nrf2 and NRF1 Synergizers, TrueScience® Anti-Aging Skin Care Regimen, Petandim®, AXIO® Smart Energy and the PhysIQ™ Smart Weight Management System. LifeVantage (Nasdaq:LFVN) was founded in 2003 and is headquartered in Salt Lake City, Utah. For more information, visit www.lifevantage.com.
Forward Looking Statements
This document contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Words and expressions reflecting optimism, satisfaction or disappointment with current prospects, as well as words such as “believe,” “hopes,” “intends,” “estimates,” “expects,” “projects,” “plans,” “anticipates,” “look forward to” and variations thereof, identify forward-looking statements, but their absence does not mean that a statement is not forward-looking. Examples of forward-looking statements include, but are not limited to, statements we make regarding our future growth, distributor success and shareholder value. Such forward-looking statements are not guarantees of performance and the Company’s actual results could differ materially from those contained in such statements. These forward-looking statements are based on the Company’s current expectations and beliefs concerning future events affecting the Company and involve known and unknown risks and uncertainties that may cause the Company’s actual results or outcomes to be materially different from those anticipated and discussed herein. These risks and uncertainties include, among others, those discussed in greater detail in the Company’s Annual Report on Form 10-K and the Company’s Quarterly Report on Form 10-Q under the caption “Risk Factors,” and in other documents filed by the Company from time to time with the Securities and Exchange Commission. The Company cautions investors not to place undue reliance on the forward-looking statements contained in this document. All forward-looking statements are based on information currently available to the Company on the date hereof, and the Company undertakes no obligation to revise or update these forward-looking statements to reflect events or circumstances after the date of this document, except as required by law.
Investor Relations Contact:
Scott Van Winkle
Managing Director, ICR